222 related articles for article (PubMed ID: 36316452)
1. Bacteriophage genome engineering with CRISPR-Cas13a.
Guan J; Oromí-Bosch A; Mendoza SD; Karambelkar S; Berry JD; Bondy-Denomy J
Nat Microbiol; 2022 Dec; 7(12):1956-1966. PubMed ID: 36316452
[TBL] [Abstract][Full Text] [Related]
2. A jumbo phage that forms a nucleus-like structure evades CRISPR-Cas DNA targeting but is vulnerable to type III RNA-based immunity.
Malone LM; Warring SL; Jackson SA; Warnecke C; Gardner PP; Gumy LF; Fineran PC
Nat Microbiol; 2020 Jan; 5(1):48-55. PubMed ID: 31819217
[TBL] [Abstract][Full Text] [Related]
3. Targeted Genome Editing of Virulent Pseudomonas Phages Using CRISPR-Cas3.
Schroven K; Voet M; Lavigne R; Hendrix H
Methods Mol Biol; 2024; 2793():113-128. PubMed ID: 38526727
[TBL] [Abstract][Full Text] [Related]
4. Efficient Genome Engineering of a Virulent Klebsiella Bacteriophage Using CRISPR-Cas9.
Shen J; Zhou J; Chen GQ; Xiu ZL
J Virol; 2018 Sep; 92(17):. PubMed ID: 29899105
[No Abstract] [Full Text] [Related]
5. Genetic Engineering of Therapeutic Phages Using Type III CRISPR-Cas Systems.
Hill CM; Hatoum-Aslan A
Methods Mol Biol; 2024; 2734():279-299. PubMed ID: 38066376
[TBL] [Abstract][Full Text] [Related]
6. A bacteriophage nucleus-like compartment shields DNA from CRISPR nucleases.
Mendoza SD; Nieweglowska ES; Govindarajan S; Leon LM; Berry JD; Tiwari A; Chaikeeratisak V; Pogliano J; Agard DA; Bondy-Denomy J
Nature; 2020 Jan; 577(7789):244-248. PubMed ID: 31819262
[TBL] [Abstract][Full Text] [Related]
7. CRISPR-Cas9 Based Bacteriophage Genome Editing.
Zhang X; Zhang C; Liang C; Li B; Meng F; Ai Y
Microbiol Spectr; 2022 Aug; 10(4):e0082022. PubMed ID: 35880867
[TBL] [Abstract][Full Text] [Related]
8. Intracellular Organization by Jumbo Bacteriophages.
Guan J; Bondy-Denomy J
J Bacteriol; 2020 Dec; 203(2):. PubMed ID: 32868402
[TBL] [Abstract][Full Text] [Related]
9. CRISPR-Cas10 assisted editing of virulent staphylococcal phages.
Nayeemul Bari SM; Hatoum-Aslan A
Methods Enzymol; 2019; 616():385-409. PubMed ID: 30691652
[TBL] [Abstract][Full Text] [Related]
10. Broad-spectrum CRISPR-Cas13a enables efficient phage genome editing.
Adler BA; Hessler T; Cress BF; Lahiri A; Mutalik VK; Barrangou R; Banfield J; Doudna JA
Nat Microbiol; 2022 Dec; 7(12):1967-1979. PubMed ID: 36316451
[TBL] [Abstract][Full Text] [Related]
11. Strategies for Editing Virulent Staphylococcal Phages Using CRISPR-Cas10.
Bari SMN; Walker FC; Cater K; Aslan B; Hatoum-Aslan A
ACS Synth Biol; 2017 Dec; 6(12):2316-2325. PubMed ID: 28885820
[TBL] [Abstract][Full Text] [Related]
12. The Phage Nucleus and PhuZ Spindle: Defining Features of the Subcellular Organization and Speciation of Nucleus-Forming Jumbo Phages.
Chaikeeratisak V; Birkholz EA; Pogliano J
Front Microbiol; 2021; 12():641317. PubMed ID: 34326818
[TBL] [Abstract][Full Text] [Related]
13. Type III CRISPR-Cas provides resistance against nucleus-forming jumbo phages via abortive infection.
Mayo-Muñoz D; Smith LM; Garcia-Doval C; Malone LM; Harding KR; Jackson SA; Hampton HG; Fagerlund RD; Gumy LF; Fineran PC
Mol Cell; 2022 Dec; 82(23):4471-4486.e9. PubMed ID: 36395770
[TBL] [Abstract][Full Text] [Related]
14. Use of Cas9 Targeting and Red Recombination for Designer Phage Engineering.
Choi SY; Romero-Calle DX; Cho HG; Bae HW; Cho YH
J Microbiol; 2024 Jan; 62(1):1-10. PubMed ID: 38300409
[TBL] [Abstract][Full Text] [Related]
15. CRISPR-Cas13 Inhibitors Block RNA Editing in Bacteria and Mammalian Cells.
Lin P; Qin S; Pu Q; Wang Z; Wu Q; Gao P; Schettler J; Guo K; Li R; Li G; Huang C; Wei Y; Gao GF; Jiang J; Wu M
Mol Cell; 2020 Jun; 78(5):850-861.e5. PubMed ID: 32348779
[TBL] [Abstract][Full Text] [Related]
16. RNA and Single-Stranded DNA Phages: Unveiling the Promise from the Underexplored World of Viruses.
Nguyen HM; Watanabe S; Sharmin S; Kawaguchi T; Tan XE; Wannigama DL; Cui L
Int J Mol Sci; 2023 Dec; 24(23):. PubMed ID: 38069353
[TBL] [Abstract][Full Text] [Related]
17. Engineering Bacteriophages as Versatile Biologics.
Kilcher S; Loessner MJ
Trends Microbiol; 2019 Apr; 27(4):355-367. PubMed ID: 30322741
[TBL] [Abstract][Full Text] [Related]
18. CRISPR-Cas: an efficient tool for genome engineering of virulent bacteriophages.
Martel B; Moineau S
Nucleic Acids Res; 2014 Aug; 42(14):9504-13. PubMed ID: 25063295
[TBL] [Abstract][Full Text] [Related]
19. [CRISPR/Cas systems in genome engineering of bacteriophages].
Liang CJ; Meng FM; Ai YC
Yi Chuan; 2018 May; 40(5):378-389. PubMed ID: 29785946
[TBL] [Abstract][Full Text] [Related]
20. Efficient engineering of a bacteriophage genome using the type I-E CRISPR-Cas system.
Kiro R; Shitrit D; Qimron U
RNA Biol; 2014; 11(1):42-4. PubMed ID: 24457913
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
